Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review

BACKGROUND: In many industrialized countries routine vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPSV-23) is recommended to prevent pneumococcal disease in the elderly. However, vaccine-induced immunity wanes after a few years, and there are controversies around revaccination...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Infect Dis
Главные авторы: Remschmidt, Cornelius, Harder, Thomas, Wichmann, Ole, Bogdan, Christian, Falkenhorst, Gerhard
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2016
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5124290/
https://ncbi.nlm.nih.gov/pubmed/27887596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-2040-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы